Heidi Hunter
Board Member
IO Biotech, Inc. (IOBTQ)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Heidi Hunter
Heidi Hunter is recorded as Board Member at IO Biotech, Inc. (IOBTQ). IO Biotech, Inc. reported in an 8-K filed March 31, 2026 that Heidi Hunter resigned as Board of Directors, effective March 31, 2026. IO Biotech, Inc. reported in an 8-K filed August 11, 2023 that Heidi Hunter was appointed Class II director, effective August 11, 2023.
“Concurrently with the Petition, on March 31, 2026, each member of the Company's board of directors, Peter Hirth, Helen Collins, Christian Elling, Kathleen Glaub, Heidi Hunter and David Smith, resigned from the Board of Directors of the Company and all of its committees.”
“On August 8, 2023, the Company appointed Heidi Hunter as a Class II director of the Company, effective as of August 11, 2023.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-08-11–present
-
2023-08-11–2026-03-31
-
2023-01-01–2026-03-31
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at IO Biotech, Inc.
Other people whose current roles at this company are on record from its filings.
- Amy Sullivan CFO
- Devin W. Smith General Counsel
- Helen Collins, M.D. Board Member
- Mai-Britt Zocca Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.